Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
about
The epidemiology of sarcomaChimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatelliteThe second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex diseaseSequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic LandscapesGenetic and nongenetic risk factors for childhood cancerPotential approaches to the treatment of Ewing's sarcomaRecent advances in targeted therapy for Ewing sarcomaCommon variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac deathClinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology GroupGenome-wide association study identifies two susceptibility loci for osteosarcomaNovel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populationsLinking germline and somatic variation in Ewing sarcomaYB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1.Comparison of Latino and non-Latino patients with Ewing sarcoma.Bone- and cartilage-forming tumors and ewing sarcoma: an update with a gnathic emphasis.Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.ERG induces epigenetic activation of Tudor domain-containing protein 1 (TDRD1) in ERG rearrangement-positive prostate cancer.The first European interdisciplinary ewing sarcoma research summitChildhood cancer: an emerging public health issue in China.Cooperation between somatic mutations and germline susceptibility variants in tumorigenesis - a dangerous liaison.Children's Oncology Group's 2013 blueprint for research: epidemiologyTat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520.Gene expression signatures of primary and metastatic uterine leiomyosarcoma.CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression.RNA-binding proteins as molecular links between cancer and neurodegeneration.Next steps in Ewing sarcoma (epi-)genomics.EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma.An EWS-FLI1-Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma DevelopmentTDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathwaysHuman HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T cells specifically inhibit Ewing sarcoma growth in vitro and in vivo.Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma.Transcriptional Regulatory Network Analysis for Gastric Cancer Based on mRNA Microarray.First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.Characterization of Ewing sarcoma associated cancer/testis antigensEWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma.[Functional genomics of Ewing sarcoma].Modeling the initiation of Ewing sarcoma tumorigenesis in differentiating human embryonic stem cells.Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells.A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus.EWS/FLI-responsive GGAA microsatellites exhibit polymorphic differences between European and African populations.
P2860
Q21195878-B3565B01-C1EC-4993-BEE8-8B70DA7DB00BQ22122062-5504DCC5-FEEA-4EF8-A97B-D7AC400BDFB8Q26775306-3E1DD2CB-063D-4FF6-9FB9-521A18174528Q26801785-B5C4266B-46A8-4C0A-BDDA-1B4353262966Q27693894-07ABCA94-D862-4F90-AC77-7E658F7257B9Q28072744-4765086D-3AFC-4885-831A-5A8E9F4E3BC7Q28079316-BD7A17CE-1B70-4753-B132-DA95A68B4730Q28294931-47C46ECA-F8B1-46CD-8579-BFDE69DB23E2Q28541625-F3DC9172-575B-4B58-A363-40FB2B885CF7Q28659642-C3D7E868-1230-4A25-AF8F-A73645A45D25Q28943485-97CC9547-D174-41D6-90E7-EE4793ECA121Q29391955-60574B50-2DE6-46FB-8632-D2DE874C9242Q30635379-A94F8CC0-7A58-42FF-948D-A84691A9256EQ34387256-7F224B6D-E344-4D50-AB2F-66B88FE1C994Q34577384-B3268E6E-B5E9-430B-B062-E979E15974BAQ34650062-6DE85379-F0FF-46DB-8CB3-596FDD3364FBQ34652823-04D221D0-FF95-47C1-8CC0-FF1E466C68C9Q35993560-0431A30A-0CF5-4A80-8DE1-F145A7E0E1C9Q36204952-66AF4853-9A25-46E6-AE53-76B1B9F46AF4Q37008602-D8DDF839-E6F2-459C-B905-5802E6FA705EQ37052986-621ECB10-FCB6-45FE-833A-0EE00AB79C80Q37582377-96875A71-1E02-4D4F-894E-EBC0DADC50C7Q37662836-2D459EF8-AA57-499B-B56E-812A95C8C879Q37718471-EF9C2016-6CD7-4B55-9EA0-73AA1F324500Q38251313-6C99B5BA-CA4B-4EF4-A102-042FDC31AFFAQ38673853-8D3BC684-F358-413B-9E99-DAAC0AB78181Q38696838-5661936F-0508-4F0E-9A47-C7DA6F04D76FQ38784600-6DD06A3F-CA1B-4BC9-BB42-65F3E4207647Q38844661-2E6858D1-A37F-4FB9-B161-91DB87E4E832Q38855717-67C2FD39-91EA-4F47-A528-4A311E4F5295Q38906382-275823D4-C4E6-4E5B-B442-CE0C61E48768Q39025662-AD12E3FF-40D1-46CB-8D5F-CCC29FF61620Q39177112-B6B255CB-A386-478B-B9B9-99A1512214A2Q39215865-E287A0D4-D0DE-4B64-A29E-6D389B1B7566Q39634845-52B8B845-ECF0-4FAE-B57A-91EFA2385F23Q40066927-1F9527B6-2D73-4AF7-BC45-E0207D31C360Q40097595-0516C76D-3ADD-430B-B902-6470480C264AQ41224633-53809637-1D96-4639-8CD4-00C236B1B9D0Q41231769-CF9FF2E9-74DC-4E20-80AA-5667DA3489D7Q42224745-63F0CE19-C4FA-43C3-9176-928741FF4121
P2860
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
@ast
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
@en
type
label
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
@ast
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
@en
prefLabel
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
@ast
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
@en
P2093
Amélie S Véron
Ana Patino-Garcia
Carlo Lucchesi
Eve Lapouble
Francois Doz
Gaelle Pierron
Gilles Thomas
Jean Michon
Karine Laud
Odile Oberlin
P2860
P2888
P304
P3181
P356
10.1038/NG.1085
P407
P50
P577
2012-02-12T00:00:00Z
P5875
P6179
1025499740